Pharmaceuticals, Biotechnology and Life Sciences
CHICAGO & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Exicure, Inc. (Nasdaq: XCUR), a pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid…
– Livoletide pivotal study in Prader-Willi syndrome (PWS) completed recruitment for patients ages 8 to 65 and is on track…
BROOKLINE, Mass.–(BUSINESS WIRE)–Navigation Sciences™ will provide an update at the annual Medtech Strategist Innovation Summit San Francisco 2019 Conference on…
Average supply expense reduction opportunity per hospital up 23% since 2017; savings achievable without negatively impacting quality WASHINGTON–(BUSINESS WIRE)–Unnecessary U.S.…
LA JOLLA, Calif.–(BUSINESS WIRE)–Avidity Biosciences, a biotechnology company pioneering Antibody-Oligonucleotide Conjugates (AOCs™) for the treatment of rare muscle disorders and…
BOSTON & LOUISVILLE, Ky.–(BUSINESS WIRE)–Third paragraph, first sentence of release dated November 7, 2019, should read: Various auto-immune diseases —…
Leading German pharmaceutical company ensures customer satisfaction through streamlined and optimized processes MUNICH & NEW YORK–(BUSINESS WIRE)–Celonis, the world leader…
–Early clinical data from Phase 1 study of MGTA-145 show successful mobilization of target number of cells in 11 of…
– KVD900 Phase 2 Clinical Trial for Treatment of Hereditary Angioedema (HAE) Expected to Complete Enrollment in 2019; Data in…
— Management to participate in two investor conferences in December 2019 — — Data from ongoing phase 2a study C-006…